InvestorsHub Logo
Followers 16
Posts 4650
Boards Moderated 0
Alias Born 08/11/2015

Re: Chaka post# 5488

Friday, 04/27/2018 5:18:37 AM

Friday, April 27, 2018 5:18:37 AM

Post# of 18220
My opinion on the news - good and bad, but overall it’s good.

Start with the bad. Noreen SUBMITTED this application for an NDA in Kenya over a year ago. See publishing on April 25, 2017. Today’s PR tells me that the first time it was submitted, it was incomplete. So the pharmacy and poison board came back to her and probably said, look we’re not accepting this, you need to have a White paper on Lodonal. So the bad is in the past. If Noreen was a good CEO, it would’ve been submitted correctly the first time, and time wouldn’t have been wasted, and she would’ve done the White paper BEFORE she was asked for it.

Anyway, the past is now in the past.

The good news is that the Lodonal White paper IS officially completed and the Pharmacy and Poison board has accepted everything for final review. So that means there’s nothing left to submit. This is good, in my opinion, mainly because it should ALSO mean that there’s nothing left to submit to NACA in Nigeria. Nigeria was probably also waiting on the White paper, so if it’s true that the white paper is all they’re waiting for, then that means we could literally have REALLY good news very soon from Nigeria. Noreen said Q3/Q4 for Kenya, but Nigeria should be before Kenya, so we can all make our own estimates based on that. Also, if the meeting with Fidson did indeed take place on March 8, then we should be hearing about Fidson contracts / NACA approval very soon now. I’m hoping anyway.

And IMO, Fidson contracts will be worth over $100m.